Li Wan Yi

Title: Innovations in Asthma Treatment by Li Wan Yi

Introduction

Li Wan Yi is a notable inventor based in Kunming, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of asthma. His innovative approach focuses on utilizing natural extracts to develop effective therapeutic compositions.

Latest Patents

Li Wan Yi holds a patent for a pharmaceutical composition aimed at preventing or treating asthma. The patent describes a composition that includes a J. Poiss. ex Franch extract or a fraction thereof. This invention is noteworthy as it does not exhibit toxicity and effectively inhibits the generation of inflammatory markers such as NO, IL-4, IL-5, and IL-13. Additionally, it reduces the production of reactive oxygen species in the bronchial tubes. The composition has shown promising results in alleviating airway hyperresponsiveness and reducing inflammatory cell infiltration in an ovalbumin-induced asthma mouse model. Furthermore, it effectively inhibits the secretion of immunoglobulins in serum and mucus in the bronchial tubes, making it a safe preparation for asthma treatment.

Career Highlights

Li Wan Yi is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on innovative research in the field of bioscience, contributing to advancements in medical treatments.

Collaborations

Li Wan Yi has collaborated with notable colleagues, including Kyung Seop Ahn and Sei Ryang Oh. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.

Conclusion

Li Wan Yi's contributions to asthma treatment through his innovative pharmaceutical compositions highlight the potential of natural extracts in medical applications. His work continues to pave the way for safer and more effective treatments for asthma patients.